Marlabs Named to CRN's 2008 Fast Growth 100

Tuesday, September 16, 2008 General News J E 4
EDISON, N.J., Sept. 16 Marlabs ranked # 72 on CRN's 2008Fast Growth 100.

The list is made up of solution providers, VARs, outsourcing firms andconsultants that have had impressive growth rates between 2005 and 2007.Companies selected for inclusion in the list distinguish themselves throughinnovative business models that can sustain rapid expansion, unique offerings,and the passion to successfully drive solutions to market.

"We owe this accolade to our emphasis on deepening customer relationshipsand delivering value in every engagement," said Siby Vadakekkara, the MarlabsCEO. "The award further underscores the robustness of our customer-centricbusiness model as well as our success in helping our clients maximize theinnovation potential of technology."

The CRN Fast Growth 100 are channel industry leaders. The five commontraits of the CRN Fast Growth Solution Providers include: multi-vendor ITsolutions; cutting-edge technologies; close customer relationships; strongsales philosophies; and business-oriented IT consulting.

"The CRN Fast Growth 100 are the cream of the crop when it comes tosolution providers who know how to wrap technology in world-class servicesofferings, and this year's group demonstrates that the technology channel isstrong and growing, regardless of surrounding economic conditions," saidRobert C. DeMarzo, Senior Vice President and Editorial Director for EverythingChannel Editorial.

About Marlabs

Marlabs is an award-winning global provider of IT services and BPOservices with dedicated industry practices in the healthcare, banking andfinancial services, insurance, media, legal and state & local governmentsectors. At Marlabs, people make the difference by consistently deliveringoutstanding value to their customers. By nurturing and empowering employees,Marlabs helps them maximize their innate potential. And drive success with acommitment and quality that first-time clients find quite astonishing.

SOURCE Marlabs Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Innovation to Design and Build High-volume Pharmac...
Newt Gingrich to Address Medicare Improvements for...